Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas

被引:2
|
作者
Orsak, Gabriela [1 ]
Miller, Anastasia [2 ]
Allen, Carlton M. [3 ]
Singh, Karan P. [1 ]
McGaha, Paul [3 ]
机构
[1] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Epidemiol & Biostat, Sch Rural & Community Hlth, 11937 US HWY 271, Tyler, TX 75708 USA
[2] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Healthcare Policy Econ & Management, Tyler, TX 75799 USA
[3] Univ Texas Tyler, Hlth Sci Ctr Tyler, Dept Community Hlth, Tyler, TX 75799 USA
关键词
COST-EFFECTIVENESS ANALYSES; UNITED-STATES; RISK-FACTOR; COLONOSCOPY; PROJECTIONS; INTERVAL; HEALTH; CARE;
D O I
10.1007/s41669-019-0147-y
中图分类号
F [经济];
学科分类号
02 ;
摘要
Background Colorectal cancer (CRC) is the third most common cancer in the USA. Its economic impact is extensive, and preventive screening services are warranted to help prevent it. Objective We sought to examine the return on investment, in terms of reduced costs attributed to cancer prevention, of a CRC screening outreach program providing education and screening in a primarily rural region targeting the uninsured and underinsured. Methods The expenditures of the Northeast Texas CRC screening program were calculated for the years of 2016 and 2017. Prices ($US) were adjusted for inflation and converted to year 2017 values. The costs saved were calculated using the estimated costs of CRC care present in the literature. Results For fiscal years 2016 and 2017, the program provided an average return of $US1.46-2.06 for every tax dollar spent. Estimated cost avoidance was $US165,080 per avoided case and estimated cost avoidance of $US245,601 among early-stage cancer cases detected, resulting in potential savings ranging from $US3,893,676 to $US4,837,923. Conclusion A CRC outreach program providing education and screening operating in less densely populated regions yields a positive return on investment.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
  • [21] Trends of utilization of various tests used for screening for colorectal cancer (CRCA) in the Medicare population
    Eloubeidi, MA
    Zhang, XZ
    Pisu, M
    Weissman, N
    Burkhardt, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S113 - S113
  • [22] False Negative Immunochemical Faecal Occult Blood Tests Due to Delayed Sample Return in Colorectal Cancer Screening
    van Rossum, Leo G.
    van Rijn, Anne Floortje
    van Oijen, Martijn G.
    Fockens, Paul
    Laheij, Robert J.
    Jansen, Jan B.
    Dekker, Evelien
    GASTROENTEROLOGY, 2009, 136 (05) : A113 - A113
  • [23] EXPANDING ACCESS TO COLORECTAL CANCER SCREENING FOR UNINSURED PATIENTS IN SOUTHWESTERN PENNSYLVANIA: A COLLABORATIVE FREE CLINIC AND ACADEMIC MEDICAL CENTER PARTNERSHIP
    Marino, Christopher C.
    Hayes, John P.
    Gochenaur, Lauren M.
    Wojcik, Rachel
    Robertson, Linda B.
    Benson, Maggie K.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 : S780 - S780
  • [24] Colorectal Cancer Screening Uptake: Differences Between Rural and Urban Privately-Insured Population
    Alyabsi, Mesnad
    Meza, Jane
    Islam, K. M. Monirul
    Soliman, Amr
    Watanabe-Galloway, Shinobu
    FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [25] Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community
    Hughes, K
    Leggett, B
    Del Mar, C
    Croese, J
    Fairley, S
    Masson, J
    Aitken, J
    Clavarino, A
    Janda, M
    Stanton, WR
    Tong, SL
    Newman, B
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2005, 29 (04) : 358 - 364
  • [26] Population health interventions to improve colorectal cancer screening by fecal immunochemical tests: A systematic review
    Issaka, Rachel B.
    Avila, Patrick
    Whitaker, Evans
    Bent, Stephen
    Somsouk, Ma
    PREVENTIVE MEDICINE, 2019, 118 : 113 - 121
  • [27] Fecal Immunochemical Tests: The Right Colorectal Cancer Screening Test for the Average- Risk Population?
    Gini, Andrea
    Selby, Kevin
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) : 2216 - 2217
  • [28] A Population-based Comparison of Immunochemical Fecal Occult Blood Tests for Colorectal Cancer Screening
    Raginel, Thibaut
    Puvinel, Josette
    Ferrand, Olivier
    Bouvier, Veronique
    Levillain, Romuald
    Ruiz, Angela
    Lantieri, Olivier
    Launoy, Guy
    Guittet, Lydia
    GASTROENTEROLOGY, 2013, 144 (05) : 918 - 925
  • [29] Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population
    van Rossum, Leo G.
    van Rijn, Anne F.
    Laheij, Robert J.
    van Oijen, Martijn G.
    Fockens, Paul
    van Krieken, Han H.
    Verbeek, Andre L.
    Jansen, Jan B.
    Dekker, Evelien
    GASTROENTEROLOGY, 2008, 135 (01) : 82 - 90
  • [30] A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening
    Grobbee, E. J.
    van der Vlugt, M.
    van Vuuren, A. J.
    Stroobants, A. K.
    Mundt, M. W.
    Spijker, W. J.
    Bongers, E. J. C.
    Kuipers, E. J.
    Lansdorp-Vogelaar, I.
    Bossuyt, P. M.
    Dekker, E.
    Spaander, M. C. W.
    GUT, 2017, 66 (11) : 1975 - 1982